226 related articles for article (PubMed ID: 21683672)
1. KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients.
Cebrian V; Fierro M; Orenes-Piñero E; Grau L; Moya P; Ecke T; Alvarez M; Gil M; Algaba F; Bellmunt J; Cordon-Cardo C; Catto J; López-Beltrán A; Sánchez-Carbayo M
Am J Pathol; 2011 Aug; 179(2):540-6. PubMed ID: 21683672
[TBL] [Abstract][Full Text] [Related]
2. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1.
Zhang Y; Huang Z; Zhu Z; Zheng X; Liu J; Han Z; Ma X; Zhang Y
PLoS One; 2014; 9(10):e104252. PubMed ID: 25272010
[TBL] [Abstract][Full Text] [Related]
3. KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer.
Moya P; Esteban S; Fernandez-Suarez A; Maestro M; Morente M; Sánchez-Carbayo M
Tumour Biol; 2013 Feb; 34(1):471-9. PubMed ID: 23132294
[TBL] [Abstract][Full Text] [Related]
4. Discovery of myopodin methylation in bladder cancer.
Cebrian V; Alvarez M; Aleman A; Palou J; Bellmunt J; Gonzalez-Peramato P; Cordón-Cardo C; García J; Piulats JM; Sánchez-Carbayo M
J Pathol; 2008 Sep; 216(1):111-9. PubMed ID: 18636402
[TBL] [Abstract][Full Text] [Related]
5. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.
Chen SQ; Chen ZH; Lin SY; Dai QB; Fu LX; Chen RQ
World J Gastroenterol; 2014 Aug; 20(29):10071-81. PubMed ID: 25110434
[TBL] [Abstract][Full Text] [Related]
6. Identification of PMF1 methylation in association with bladder cancer progression.
Aleman A; Cebrian V; Alvarez M; Lopez V; Orenes E; Lopez-Serra L; Algaba F; Bellmunt J; López-Beltrán A; Gonzalez-Peramato P; Cordon-Cardo C; García J; del Muro JG; Esteller M; Sánchez-Carbayo M
Clin Cancer Res; 2008 Dec; 14(24):8236-43. PubMed ID: 19088041
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer.
Esteban S; Moya P; Fernandez-Suarez A; Vidaurreta M; González-Peramato P; Sánchez-Carbayo M
Tumour Biol; 2012 Apr; 33(2):337-46. PubMed ID: 22252522
[TBL] [Abstract][Full Text] [Related]
8. Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors.
García-Baquero R; Puerta P; Beltran M; Alvarez-Mújica M; Alvarez-Ossorio JL; Sánchez-Carbayo M
Tumour Biol; 2014 Jun; 35(6):5777-86. PubMed ID: 24577895
[TBL] [Abstract][Full Text] [Related]
9. Reduced Kiss‑1 expression is associated with clinical aggressive feature of gastric cancer patients and promotes migration and invasion in gastric cancer cells.
Li C; Yuan L; Han S; Xuan M; Liu D; Tian B; Yu W
Oncol Rep; 2020 Sep; 44(3):1149-1157. PubMed ID: 32705229
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
[TBL] [Abstract][Full Text] [Related]
12. Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays.
Aleman A; Adrien L; Lopez-Serra L; Cordon-Cardo C; Esteller M; Belbin TJ; Sanchez-Carbayo M
Br J Cancer; 2008 Jan; 98(2):466-73. PubMed ID: 18087279
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.
Arab K; Smith LT; Gast A; Weichenhan D; Huang JP; Claus R; Hielscher T; Espinosa AV; Ringel MD; Morrison CD; Schadendorf D; Kumar R; Plass C
Carcinogenesis; 2011 Oct; 32(10):1467-73. PubMed ID: 21771727
[TBL] [Abstract][Full Text] [Related]
14. A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression.
Vallot C; Stransky N; Bernard-Pierrot I; Hérault A; Zucman-Rossi J; Chapeaublanc E; Vordos D; Laplanche A; Benhamou S; Lebret T; Southgate J; Allory Y; Radvanyi F
J Natl Cancer Inst; 2011 Jan; 103(1):47-60. PubMed ID: 21173382
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer.
Dudziec E; Miah S; Choudhry HM; Owen HC; Blizard S; Glover M; Hamdy FC; Catto JW
Clin Cancer Res; 2011 Mar; 17(6):1287-96. PubMed ID: 21138856
[TBL] [Abstract][Full Text] [Related]
16. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
[TBL] [Abstract][Full Text] [Related]
17. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
[TBL] [Abstract][Full Text] [Related]
18. CpG hypermethylation of collagen type I alpha 2 contributes to proliferation and migration activity of human bladder cancer.
Mori K; Enokida H; Kagara I; Kawakami K; Chiyomaru T; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Int J Oncol; 2009 Jun; 34(6):1593-602. PubMed ID: 19424577
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation in bladder cancer: biological pathways and translational applications.
Sánchez-Carbayo M
Tumour Biol; 2012 Apr; 33(2):347-61. PubMed ID: 22274923
[TBL] [Abstract][Full Text] [Related]
20. Assessment of epigenetic contributions to sexually-dimorphic Kiss1 expression in the anteroventral periventricular nucleus of mice.
Semaan SJ; Dhamija S; Kim J; Ku EC; Kauffman AS
Endocrinology; 2012 Apr; 153(4):1875-86. PubMed ID: 22374971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
